Figure 3From: Cytotoxic T lymphocyte responses against melanocytes and melanomaDegranulation responses in ex vivo PBMC samples from peptide-vaccinated melanoma patients against melanocyte and melanoma cell lines. PBMC samples were collected from two post-vaccinated melanoma patients (patient identification numbers 10820 and 10839). FACS plots demonstrating CD107 versus CD8 levels in the two patient samples after contact with the target cell lines. CD8-positive cells were further gated, showing percentage of CTLs staining positive for CD107 mobilization.Back to article page